These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 24161123)

  • 1. Prostate transglutaminase (TGase-4, TGaseP) enhances the adhesion of prostate cancer cells to extracellular matrix, the potential role of TGase-core domain.
    Jiang WG; Ye L; Sanders AJ; Ruge F; Kynaston HG; Ablin RJ; Mason MD
    J Transl Med; 2013 Oct; 11():269. PubMed ID: 24161123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate transglutaminase (TGase-4) antagonizes the anti-tumour action of MDA-7/IL-24 in prostate cancer.
    Ablin RJ; Kynaston HG; Mason MD; Jiang WG
    J Transl Med; 2011 Apr; 9():49. PubMed ID: 21524313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prostate transglutaminase (TGase-4, TGaseP) regulates the interaction of prostate cancer and vascular endothelial cells, a potential role for the ROCK pathway.
    Jiang WG; Ablin RJ; Kynaston HG; Mason MD
    Microvasc Res; 2009 Mar; 77(2):150-7. PubMed ID: 18983858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prostate transglutaminase, TGase-4, coordinates with the HGFL/MSP-RON system in stimulating the migration of prostate cancer cells.
    Jiang WG; Ye L; Ablin RJ; Kynaston HG; Mason MD
    Int J Oncol; 2010 Aug; 37(2):413-8. PubMed ID: 20596668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the prostate transglutaminase (TGase-4) in prostate cancer cells and its impact on the invasiveness of prostate cancer.
    Davies G; Ablin RJ; Mason MD; Jiang WG
    J Exp Ther Oncol; 2007; 6(3):257-64. PubMed ID: 17552366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological characterization and activity of transglutaminases in human normal and malignant prostate and in prostate cancer cell lines.
    Friedrichs B; Riedmiller H; Goebel HW; Rausch U; Aumüller G
    Urol Res; 1995; 23(5):301-310. PubMed ID: 8839386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate Transglutaminase (TGase-4) Induces Epithelial-to-Mesenchymal Transition in Prostate Cancer Cells.
    Ablin RJ; Owen S; Jiang WG
    Anticancer Res; 2017 Feb; 37(2):481-487. PubMed ID: 28179293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myoferlin depletion elevates focal adhesion kinase and paxillin phosphorylation and enhances cell-matrix adhesion in breast cancer cells.
    Blackstone BN; Li R; Ackerman WE; Ghadiali SN; Powell HM; Kniss DA
    Am J Physiol Cell Physiol; 2015 Apr; 308(8):C642-9. PubMed ID: 25631868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recruitment of focal adhesion kinase and paxillin to beta1 integrin promotes cancer cell migration via mitogen activated protein kinase activation.
    Crowe DL; Ohannessian A
    BMC Cancer; 2004 May; 4():18. PubMed ID: 15132756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic upregulation of matriptase-2 reduces the aggressiveness of prostate cancer cells in vitro and in vivo and affects FAK and paxillin localisation.
    Sanders AJ; Parr C; Martin TA; Lane J; Mason MD; Jiang WG
    J Cell Physiol; 2008 Sep; 216(3):780-9. PubMed ID: 18449907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bombesin stimulates the motility of human prostate-carcinoma cells through tyrosine phosphorylation of focal adhesion kinase and of integrin-associated proteins.
    Aprikian AG; Tremblay L; Han K; Chevalier S
    Int J Cancer; 1997 Jul; 72(3):498-504. PubMed ID: 9247295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The membrane-targeted alkylphosphocholine erufosine interferes with survival signals from the extracellular matrix.
    Chometon G; Cappuccini F; Raducanu A; Aumailley M; Jendrossek V
    Anticancer Agents Med Chem; 2014 May; 14(4):578-91. PubMed ID: 24628265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the Metastasis Suppressor, N-Myc Downstream Regulated Gene-1, with Novel Di-2-Pyridylketone Thiosemicarbazones: Suppression of Tumor Cell Migration and Cell-Collagen Adhesion by Inhibiting Focal Adhesion Kinase/Paxillin Signaling.
    Wangpu X; Lu J; Xi R; Yue F; Sahni S; Park KC; Menezes S; Huang ML; Zheng M; Kovacevic Z; Richardson DR
    Mol Pharmacol; 2016 May; 89(5):521-40. PubMed ID: 26895766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular transglutaminase has affinity for extracellular matrix.
    Upchurch HF; Conway E; Patterson MK; Birckbichler PJ; Maxwell MD
    In Vitro Cell Dev Biol; 1987 Nov; 23(11):795-800. PubMed ID: 2890619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of lysophosphatidic acid on calpain-mediated proteolysis of focal adhesion kinase in human prostate cancer cells.
    Park JJ; Rubio MV; Zhang Z; Um T; Xie Y; Knoepp SM; Snider AJ; Gibbs TC; Meier KE
    Prostate; 2012 Nov; 72(15):1595-610. PubMed ID: 22473839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyaluronic acid induces transglutaminase II to enhance cell motility; role of Rac1 and FAK in the induction of transglutaminase II.
    Kim Y; Park YW; Lee YS; Jeoung D
    Biotechnol Lett; 2008 Jan; 30(1):31-9. PubMed ID: 17680210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The core domain of the tissue transglutaminase Gh hydrolyzes GTP and ATP.
    Iismaa SE; Chung L; Wu MJ; Teller DC; Yee VC; Graham RM
    Biochemistry; 1997 Sep; 36(39):11655-64. PubMed ID: 9305955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The HGF/SF-induced phosphorylation of paxillin, matrix adhesion, and invasion of prostate cancer cells were suppressed by NK4, an HGF/SF variant.
    Parr C; Davies G; Nakamura T; Matsumoto K; Mason MD; Jiang WG
    Biochem Biophys Res Commun; 2001 Aug; 285(5):1330-7. PubMed ID: 11478803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The chemopreventive bioflavonoid apigenin inhibits prostate cancer cell motility through the focal adhesion kinase/Src signaling mechanism.
    Franzen CA; Amargo E; Todorović V; Desai BV; Huda S; Mirzoeva S; Chiu K; Grzybowski BA; Chew TL; Green KJ; Pelling JC
    Cancer Prev Res (Phila); 2009 Sep; 2(9):830-41. PubMed ID: 19737984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Focal adhesion kinase controls prostate cancer progression via intrinsic kinase and scaffolding functions.
    Figel S; Gelman IH
    Anticancer Agents Med Chem; 2011 Sep; 11(7):607-16. PubMed ID: 21355844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.